Wei‐Ling Tsou

877 total citations
24 papers, 654 citations indexed

About

Wei‐Ling Tsou is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Wei‐Ling Tsou has authored 24 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Wei‐Ling Tsou's work include Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (15 papers) and Ubiquitin and proteasome pathways (12 papers). Wei‐Ling Tsou is often cited by papers focused on Genetic Neurodegenerative Diseases (18 papers), Mitochondrial Function and Pathology (15 papers) and Ubiquitin and proteasome pathways (12 papers). Wei‐Ling Tsou collaborates with scholars based in United States and Taiwan. Wei‐Ling Tsou's co-authors include Sokol V. Todi, Jessica R. Blount, Michelle Ouyang, K. Matthew Scaglione, Bridget B. Baker, Henry L. Paulson, Danielle Meyer, Camille Akemann, Yongli Zhang and Tracie R. Baker and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Wei‐Ling Tsou

23 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Ling Tsou United States 14 468 314 112 79 78 24 654
Lena Will Netherlands 10 288 0.6× 126 0.4× 51 0.5× 22 0.3× 27 0.3× 13 568
Gonzalo Blanco United Kingdom 15 420 0.9× 59 0.2× 86 0.8× 28 0.4× 26 0.3× 30 660
Lata Mahishi United States 9 413 0.9× 192 0.6× 34 0.3× 14 0.2× 33 0.4× 11 545
Abdul Hameed Pakistan 12 346 0.7× 26 0.1× 30 0.3× 36 0.5× 8 0.1× 21 620
SoRi Jang United States 5 230 0.5× 73 0.2× 43 0.4× 16 0.2× 16 0.2× 5 351
Chuanyu Liu China 11 272 0.6× 58 0.2× 10 0.1× 23 0.3× 39 0.5× 62 516
Mikio Sasoh Japan 13 189 0.4× 28 0.1× 80 0.7× 30 0.4× 22 0.3× 41 749
Lucy Crompton United Kingdom 9 488 1.0× 66 0.2× 4 0.0× 21 0.3× 24 0.3× 17 660
Sonia Mayo Spain 14 341 0.7× 31 0.1× 43 0.4× 52 0.7× 9 0.1× 32 814
Naoko Tsuzaki Japan 8 158 0.3× 72 0.2× 11 0.1× 21 0.3× 20 0.3× 9 368

Countries citing papers authored by Wei‐Ling Tsou

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ling Tsou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ling Tsou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ling Tsou more than expected).

Fields of papers citing papers by Wei‐Ling Tsou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ling Tsou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ling Tsou. The network helps show where Wei‐Ling Tsou may publish in the future.

Co-authorship network of co-authors of Wei‐Ling Tsou

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ling Tsou. A scholar is included among the top collaborators of Wei‐Ling Tsou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ling Tsou. Wei‐Ling Tsou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todi, Sokol V., et al.. (2025). The effect of AKT inhibition in α-synuclein-dependent neurodegeneration. Frontiers in Molecular Neuroscience. 18. 1524044–1524044. 1 indexed citations
2.
3.
Tsou, Wei‐Ling, et al.. (2025). Insights into dentatorubral-pallidoluysian atrophy from a new Drosophila model of disease. Neurobiology of Disease. 207. 106834–106834. 1 indexed citations
4.
Sujkowski, Alyson, et al.. (2024). Progressive degeneration in a new Drosophila model of spinocerebellar ataxia type 7. Scientific Reports. 14(1). 14332–14332. 2 indexed citations
5.
Tsou, Wei‐Ling, et al.. (2023). Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3. Frontiers in Neuroscience. 16. 1112688–1112688. 4 indexed citations
6.
Blount, Jessica R., et al.. (2023). Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3. Journal of the Neurological Sciences. 454. 120828–120828. 2 indexed citations
7.
Tsou, Wei‐Ling, et al.. (2022). A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases. Frontiers in Molecular Neuroscience. 15. 974167–974167. 14 indexed citations
8.
Blount, Jessica R., et al.. (2021). Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3. Neurobiology of Disease. 160. 105516–105516. 10 indexed citations
9.
10.
Meyer, Danielle, Camille Akemann, Bridget B. Baker, et al.. (2020). Nanoplastics impact the zebrafish (Danio rerio) transcriptome: Associated developmental and neurobehavioral consequences. Environmental Pollution. 266(Pt 2). 115090–115090. 125 indexed citations
11.
Blount, Jessica R., et al.. (2020). Degron capability of the hydrophobic C‐terminus of the polyglutamine disease protein, ataxin‐3. Journal of Neuroscience Research. 98(10). 2096–2108. 5 indexed citations
12.
Blount, Jessica R., et al.. (2019). Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3. Neurobiology of Disease. 132. 104535–104535. 20 indexed citations
13.
Tsou, Wei‐Ling, et al.. (2016). USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila. Journal of Biological Chemistry. 291(17). 9161–9172. 13 indexed citations
14.
Tsou, Wei‐Ling, et al.. (2015). DnaJ-1 and karyopherin α3 suppress degeneration in a newDrosophilamodel of Spinocerebellar Ataxia Type 6. Human Molecular Genetics. 24(15). 4385–4396. 38 indexed citations
15.
Tsou, Wei‐Ling, et al.. (2015). The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster. Neurobiology of Disease. 82. 12–21. 45 indexed citations
16.
Blount, Jessica R., et al.. (2014). Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23. Nature Communications. 5(1). 4638–4638. 58 indexed citations
17.
Tsou, Wei‐Ling, et al.. (2014). An optimal ubiquitin-proteasome pathway in the nervous system: the role of deubiquitinating enzymes. Frontiers in Molecular Neuroscience. 7. 72–72. 63 indexed citations
18.
Tsou, Wei‐Ling, et al.. (2013). Ubiquitination Regulates the Neuroprotective Function of the Deubiquitinase Ataxin-3 in Vivo. Journal of Biological Chemistry. 288(48). 34460–34469. 50 indexed citations
19.
Tsou, Wei‐Ling, et al.. (2012). Systematic Analysis of the Physiological Importance of Deubiquitinating Enzymes. PLoS ONE. 7(8). e43112–e43112. 58 indexed citations
20.
Tsou, Wei‐Ling, Bing‐Wen Soong, Henry L. Paulson, & Edgardo Rodríguez-Lebrón. (2011). Splice isoform-specific suppression of the CaV2.1 variant underlying spinocerebellar ataxia type 6. Neurobiology of Disease. 43(3). 533–542. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lena Will Breakdown of academic impact, for papers by Gonzalo Blanco Breakdown of academic impact, for papers by Lata Mahishi Breakdown of academic impact, for papers by Abdul Hameed Breakdown of academic impact, for papers by SoRi Jang Breakdown of academic impact, for papers by Chuanyu Liu Breakdown of academic impact, for papers by Mikio Sasoh Breakdown of academic impact, for papers by Lucy Crompton Breakdown of academic impact, for papers by Sonia Mayo Breakdown of academic impact, for papers by Naoko Tsuzaki
Rankless by CCL
2026